Short-term outcomes of ESWT versus Botox injections for treatment of plantar fasciitis .
This report has been verified
by one or more authors of the
original publication.
Comparison of extracorporeal shock wave therapy with botulinum toxin type A in the treatment of plantar fasciitis
Disabil Rehabil. 2016 Oct;38(21):2114-2174 patients with plantar fasciitis were randomized to treatment with either extracorporeal shockwave therapy (ESWT) or botulinum toxin type A (BoNT-A) injections. The purpose of this study was to compare pain on a visual analog scale (VAS), Roles and Maudsley pain scores, plantar fasciitis thickness on ultrasound, and the incidence of adverse events. Patients were followed-up at 1 month. The ESWT group demonstrated a greater reduction in VAS pain at rest and on the Roles and Maudsley score compared to the BoNT-A injections. No significant difference in the incidence of adverse events was observed between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
